GLO1 and neoplasm: The overexpression of Glo1 in tumor cells makes this enzyme a pivotal target for anticancer drug development, and, in fact, Glo1 inhibitors, alone or in combination with other drugs, have offered potential benefit in the management of some human malignancies [21,22,23].